Support The Moscow Times!
Contribute today
My account
Signout
×
Sections
Home
Ukraine War
News
Climate
Opinion
Business
Arts and Life
Regions
Podcasts
Galleries
Newsletters
TMT Lecture Series
Archive
Multimedia projects
Mothers & Daughters
Generation P
News
Ukraine War
Climate
Regions
Business
Meanwhile
Opinion
Podcasts
Archive
RU
My account
Signout
Support The Moscow Times!
Contribute today
Articles by Sergey Klimenko
news
B2B: Parallel Import of Medicines: High Time or the Wrong Time?
Russia is still heavily dependent on foreign medicines.
news
B2B: Foreign Medical Device Manufacturers: Should You Stay or Should You Go?
Although the conditions for entering the market have been reshaped, the legislation is about to give investors tools they never had before.
news
B2B: User-Friendly Legal Interface for the Life Sciences Market
Quite often, when describing the situation with regulating a specific Russian industry, we could construct analogies with the world of software, where...